A comprehensive review and meta-analysis of risk factors for statin-induced myopathy
ConclusionsThis comprehensive assessment of risk factors can help support clinicians in reducing the incidence of SIM in their patient population on statins.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Drugs & Pharmacology | Endocrinology | Genetics | Heart | Liver | Rhabdomyolysis | Statin Therapy | Statistics | Urology & Nephrology